Bridging of a substrate between cyclodextrin and an enzyme's active site pocket triggers a unique mode of inhibition

Due to its potential interaction with physiological proteins via sequestered substrates, caution must be exercised in HP-β-CD mediated delivery of drugs under pathophysiological conditions.